Correlation between a single nucleotide polymorphism (G/T at nt –88) in the Mx1 gene promoter and the response to interferon therapy for hepatitis C virus in Egyptian patients
Pooneh Mokarram
African Journal of Biotechnology, 2011
View PDFchevron_right
Assessment of the Relation Between SNP in MxA Gene and the Responsiveness of Egyptian HCV Genotype 4 Patients to Pegylated Interferon and Ribavirin Treatment
Mohamed Hassany
Gastroenterology Research, 2017
View PDFchevron_right
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR
Howard Thomas
Genes and Immunity, 2003
View PDFchevron_right
Polymorphisms in the interferon-γ gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-α and ribavirin
Wan-long Chuang
Antiviral Research, 2005
View PDFchevron_right
MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients
Wahid Doss
Journal of Viral Hepatitis, 2010
View PDFchevron_right
Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection
Fahmy Ali
Gut and liver, 2015
View PDFchevron_right
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial
Richard Sterling
Hepatology, 2009
View PDFchevron_right
Association of SNPs in Interferon Receptor Genes in Chronic Hepatitis C with Response to Combined Therapy of Interferon and Ribavirin
K. Shahzamani
2013
View PDFchevron_right
Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection
Giuliano Ramadori
European Journal of Gastroenterology & Hepatology, 2006
View PDFchevron_right
The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern Iran
Neda Pirbonyeh
Hepatitis monthly, 2014
View PDFchevron_right
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
Ali Pouryasin, Heidar Sharafi
World Journal of Gastroenterology, 2015
View PDFchevron_right
Polymorphisms in the IFN-induced GENES PKR, OAS-1, MxA and the outcome of hepatitis C virus infection
Susanne Knapp
Journal of Hepatology, 2002
View PDFchevron_right
Comparison of Interferon-Gamma (IFNG) +874 T/A Single Nucleotide Polymorphism in Hepatitis C Virus Infected Patients and Non-Infected Controls in Mashhad, Iran
mojtaba meshkat
Iranian Journal of Pathology
View PDFchevron_right
Association of interferon gamma gene polymorphism and susceptibility to hepatitis C virus infection in Egyptian patients: A multicenter, family‐based study
Maged El-Setouhy
JGH Open: An Open Access Journal of Gastroenterology and Hepatology, 2017
View PDFchevron_right
Single-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide −443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C
Olfat Shaker
Human Immunology, 2012
View PDFchevron_right
Human Leukocyte Antigen Class I Alleles can Predict Response to Pegylated Interferon/Ribavirin Therapy in Chronic Hepatitis C Egyptian Patients
Raghda Farag, Hatem Elalfy
Archives of Iranian Medicine, 2013
View PDFchevron_right
Association between low molecular polypeptide 7 single nucleotide polymorphism and response to therapy in hepatitis C virus infection
Samar Youssef, Wafaa Shosha
World journal of hepatology, 2013
View PDFchevron_right
Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C
sanaz mahmazi
Iranian Red Crescent Medical Journal, 2016
View PDFchevron_right
NS5A Sequence Heterogeneity of Hepatitis C Virus Genotype 4a Predicts Clinical Outcome of Pegylated-Interferon-Ribavirin Therapy in Egyptian Patients
Wafaa Elakel, Ahmed Elshamy, Ikuo Shoji, Lin Deng
Journal of Clinical Microbiology, 2012
View PDFchevron_right
Impact of gene polymorphism on Egyptian HCV patients under direct antiviral Drugs
Amany M. Mohmmed
Biochemistry Letters, 2020
View PDFchevron_right
Changes in Gene Expression during Pegylated Interferon and Ribavirin Therapy of Chronic Hepatitis C Virus Distinguish Responders from Nonresponders to Antiviral Therapy
Jeanette McClintick
Journal of Virology, 2007
View PDFchevron_right
Role of interferon gamma gene polymorphism in spontaneous viral clearance versus chronicity in hepatitis C infected Egyptian patients
Dina Adel
Medical Journal of Viral Hepatitis, 2021
View PDFchevron_right